CEO
Sai Life Sciences Limited
Equibles does not estimate personal net worth.
Krishna Kanamari is recorded as CEO at Sai Life Sciences Limited. Krishna Kanamari has spoken on 2 earnings calls across 1 company, most recently for Sai Life Sciences Limited on May 15, 2026. Sai Life Sciences Limited is classified in the Diagnostics & Research industry within the Healthcare sector.
“We are pleased to report that FI Life Sciences has delivered a strong performance in FY26, with overall revenue growth of 29%, EBITDA growth of 56%, and PAC growth of 109%.”
“I'm happy to share with you my reflections on the quarter. The global microenvironment continues to be supportive of our industry, with India increasingly positioned as a preferred destination for pharmaceutical cloud sourcing.”
Sai Life Sciences Limited
CEO
Transcript header (unverified)
Sai Life Sciences Limited
Diagnostics & Research · Healthcare
CEO
Sai Life Sciences Limited Q4 FY26 Earnings Conference Call
Sai Life Sciences Limited
Sai Life Sciences Limited Q3 FY ‘26 Earnings Conference Call
Sai Life Sciences Limited
